| Financial Year |
March 31 2023 |
| Monetary Funds |
2,723,218,942.13 |
| Held-for-trading Financial Assets |
2,703,735,919.93 |
| Notes Receivable |
157,829,411.24 |
| Accounts Receivable |
3,221,708,984.08 |
| Advances to Suppliers |
109,091,878.55 |
| Other Receivables |
977,923,569.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,123,852,655.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
329,385,273.30 |
| Total Current Assets |
14,161,563,359.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,720,686,889.57 |
| Investment Properties |
61,220,190.34 |
| Fixed Assetes |
3,700,471,878.68 |
| Under-construction Projects |
603,583,104.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
488,871,843.89 |
| R&D expenses |
-- |
| Goodwill |
239,525,515.71 |
| Long-Term Deferred and Prepaid Expenses |
28,602,675.96 |
| Deferred Income Tax Assets |
255,025,727.38 |
| Other Non-Current Assets |
551,913,640.12 |
| Sub-Total of Non-Current Assets |
14,753,588,067.14 |
| Total Assets |
28,915,151,426.72 |
| Short-Term Loans |
3,771,039,655.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,565,521,102.56 |
| Accounts Payable |
3,228,534,201.61 |
| Accounts Received In Advance |
137,737.06 |
| Employee Compensation Payable |
211,084,109.98 |
| Taxes Payable |
72,213,770.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
198,346,860.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,661,346.57 |
| Other Current Liabilities |
231,169,144.48 |
| Sub-Total of Current Liabilities |
9,410,454,190.94 |
| Long-term Loans |
225,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,785,082.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,758,676.14 |
| Deferred Income Tax Liabilities |
34,567,821.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
698,756,854.29 |
| Total Liabilities |
10,109,211,045.23 |
| Paid-In Capital(Or Share Stock) |
1,008,173,293.00 |
| Capital Surplus |
3,396,277,545.41 |
| Surplus Reserve |
510,100,496.00 |
| LESS:Treasury Stock |
608,217,152.24 |
| Undistributed Profits |
13,734,796,002.33 |
| Minority Stockholder's Interest |
753,807,134.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,052,133,247.44 |
| Owner's Equity（Stockholder's Equity） |
18,805,940,381.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,915,151,426.72 |
